Evidence map›Paper›PMID 37392234›Full record

ArticleEuropean journal of pediatrics2023

The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network.

Christina B Ching, Kimberley Dickinson, John Karafilidis, Nicole Marchesani, Lisa Mucha, Nuno Antunes, Hanieh Razzaghi, Levon Utidjian, Karyn Yonekawa, Douglas E Coplen and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Christina B ChingDepartment of Pediatric Urology, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. christina.ching@nationwidechildrens.org.ORCID http://orcid.org/0000-0002-3396-4215
Kimberley DickinsonApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
John KarafilidisDicerna Pharmaceuticals, Cambridge, MA, USA.
Nicole MarchesaniApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Lisa MuchaDicerna Pharmaceuticals, Cambridge, MA, USA.
Nuno AntunesDicerna Pharmaceuticals, Cambridge, MA, USA.
Hanieh RazzaghiApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Levon UtidjianDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Karyn YonekawaDepartment of Pediatrics, Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.
Douglas E CoplenDepartment of Surgery, Division of Urology, St. Louis Children's Hospital, St. Louis, MO, USA.
Samina MuneeruddinDepartment of Pediatrics, Division of Nephrology, AI DuPont Children's Hospital, Wilmington, DE, USA.
William DeFoorDepartment of Surgery, Division of Urology, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, USA.
Kyle O RoveDepartment of Pediatric Urology, Children's Hospital Colorado, Aurora, CO, USA.
Christopher B ForrestApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Gregory E TasianDepartment of Surgery, Division of Urology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Children's Hospital of Philadelphia · USDicerna Pharmaceuticals (United States) · USChildren's Hospital Colorado · USCincinnati Children's Hospital Medical Center · USDuPont (United States) · USNationwide Children's Hospital · USSeattle Children's Hospital · USSt. Louis Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rarity of primary hyperoxaluria (PH) challenges our understanding of the disease. The purpose of our study was to describe the course of clinical care in a United States cohort of PH pediatric patients, highlighting health service utilization. We performed a retrospective cohort study of PH patients < 18 years old in the PEDSnet clinical research network from 2009 to 2021. Outcomes queried included diagnostic imaging and testing related to known organ involvement of PH, surgical and medical interventions specific to PH-related renal disease, and select PH-related hospital service utilization. Outcomes were evaluated relative to cohort entrance date (CED), defined as date of first PH-related diagnostic code. Thirty-three patients were identified: 23 with PH type 1; 4 with PH type 2; 6 with PH type 3. Median age at CED was 5.0 years (IQR 1.4, 9.3 years) with the majority being non-Hispanic white (73%) males (70%). Median follow-up between CED and most recent encounter was 5.1 years (IQR 1.2, 6.8). Nephrology and Urology were the most common specialties involved in care, with low utilization of other sub-specialties (12%-36%). Most patients (82%) had diagnostic imaging used to evaluate kidney stones; 11 (33%) had studies of extra-renal involvement. Stone surgery was performed in 15 (46%) patients. Four patients (12%) required dialysis, begun in all prior to CED; four patients required renal or renal/liver transplant.    Conclusion: In this large cohort of U.S. PH children, patients required heavy health care utilization with room for improvement in involving multi-disciplinary specialists. What is Known: • Primary hyperoxaluria (PH) is rare with significant implications on patient health. Typical involvement includes the kidneys; however, extra-renal manifestations occur. • Most large population studies describe clinical manifestations and involve registries. What is New: • We report the clinical journey, particularly related to diagnostic studies, interventions, multispecialty involvement, and hospital utilization, of a large cohort of PH pediatric patients in the PEDSnet clinical research network. • There are missed opportunities, particularly in that of specialty care, that could help in the diagnosis, treatment, and even prevention of known clinical manifestations.

Indexed as

Hyperoxaluria, PrimaryAdolescentChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesUnited StatesChronic kidney failureNephrolithiasisNephrologyPrimary hyperoxaluriaTreatment outcomeUrology

Identifiers

PMID37392234
OpenAlexW4382797324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.